These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9012144)

  • 1. [Diagnosis of thrombophilia--cui bono?].
    Lechner K
    Wien Klin Wochenschr; 1996; 108(19):595-8. PubMed ID: 9012144
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma resistance to activated protein C: an important link between venous thromboembolism and combined oral contraceptives--a short review.
    Jespersen J
    Eur J Contracept Reprod Health Care; 1996; 1(1):3-11. PubMed ID: 9678132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombophilia: the discovery of activated protein C resistance.
    Dahlbäck B
    Adv Genet; 1995; 33():135-75. PubMed ID: 7484452
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular implications of the factor V Leiden mutation.
    Major DA; Sane DC; Herrington DM
    Am Heart J; 2000 Aug; 140(2):189-95. PubMed ID: 10925328
    [No Abstract]   [Full Text] [Related]  

  • 5. Venous thromboembolism: implications for gene-based diagnosis and technology development.
    Hooper WC; De Staercke C
    Expert Rev Mol Diagn; 2002 Nov; 2(6):576-86. PubMed ID: 12465454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation factor V and thrombophilia: background and mechanisms.
    Segers K; Dahlbäck B; Nicolaes GA
    Thromb Haemost; 2007 Sep; 98(3):530-42. PubMed ID: 17849041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
    Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM
    Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of venous thromboembolism in families with inherited thrombophilia.
    Simioni P; Sanson BJ; Prandoni P; Tormene D; Friederich PW; Girolami B; Gavasso S; Huisman MV; Büller HR; Wouter ten Cate J; Girolami A; Prins MH
    Thromb Haemost; 1999 Feb; 81(2):198-202. PubMed ID: 10063991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of primary antiphospholipid syndrome with inherited activated protein C resistance.
    Picillo U; De Lucia D; Palatiello E; Scuotto A; Marcialis MR; Pezzella S; Tirri G
    J Rheumatol; 1998 Jun; 25(6):1232-4. PubMed ID: 9632093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Leiden Thrombophilia Study (LETS).
    van der Meer FJ; Koster T; Vandenbroucke JP; Briët E; Rosendaal FR
    Thromb Haemost; 1997 Jul; 78(1):631-5. PubMed ID: 9198229
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of factor V deficiency with factor V HR2.
    Faioni EM; Castaman G; Asti D; Lussana F; Rodeghiero F
    Haematologica; 2004 Feb; 89(2):195-200. PubMed ID: 15003895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of thrombotic children with malignancy.
    Unal S; Varan A; Yalçin B; Büyükpamukçu M; Gürgey A
    Ann Hematol; 2005 Jun; 84(6):395-9. PubMed ID: 15735962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inherited thrombophilia and the eye.
    Czerlanis C; Jay WM; Nand S
    Semin Ophthalmol; 2008; 23(2):111-9. PubMed ID: 18320477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboepidemiology: identifying patients with heritable risk for thrombin-mediated thromboembolic events.
    Tran M; Spencer FA
    Am Heart J; 2005 Jan; 149(1 Suppl):S9-18. PubMed ID: 15644796
    [No Abstract]   [Full Text] [Related]  

  • 15. Thrombophilia and venous thromboembolism: implications for testing.
    Cohn DM; Roshani S; Middeldorp S
    Semin Thromb Hemost; 2007 Sep; 33(6):573-81. PubMed ID: 17768689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Third generation oral contraceptives and heritable thrombophilia as risk factors of non-fatal venous thromboembolism.
    Andersen BS; Olsen J; Nielsen GL; Steffensen FH; Sørensen HT; Baech J; Gregersen H
    Thromb Haemost; 1998 Jan; 79(1):28-31. PubMed ID: 9459317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S.
    De Stefano V; Simioni P; Rossi E; Tormene D; Za T; Pagnan A; Leone G
    Haematologica; 2006 May; 91(5):695-8. PubMed ID: 16670075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor V Leiden and prothrombin gene 20210A variant in neonatal thromboembolism and in healthy neonates and adults: a study in a single center.
    Atasay B; Arsan S; Günlemez A; Kemahli S; Akar N
    Pediatr Hematol Oncol; 2003 Dec; 20(8):627-34. PubMed ID: 14578033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous thrombin potential for predicting risk of venous thromboembolism in carriers of factor V Leiden.
    Lincz LF; Lonergan A; Scorgie FE; Rowlings P; Gibson R; Lawrie A; Seldon M
    Pathophysiol Haemost Thromb; 2006; 35(6):435-9. PubMed ID: 17565236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.